By MEGHAN KENEALLY
15 hours ago
Nebraska Ebola Patient Getting Same Experimental Drug As Texas Patient (ABC News)
"After looking at the data on this drug, collaborating with the CDC
and FDA and speaking with the patient and his family, we decided this
was currently our best option for treatment," said Dr. Phil Smith, the
medical director of the biocontainment unit at Nebraska Medical Center
where Ashoka Mukpo is being treated.
What to Know About the Experimental Drug Being Given to the Texas Ebola PatientTexas Ebola Patient Thomas Eric Duncan Now Getting Experimental Drug
Both Mukpo, a freelance cameraman who was working with NBC in Liberia
when he tested positive for the disease, and Thomas Eric Duncan, a
Liberian man visiting family in America, are being treated with brincidofovir.
"Every
patient is somewhat different, and we believe Brincidofovir is the best
choice," Smith said in a statement released today.
The
drug is produced by a North Carolina-based biopharmaceutical company
and was authorized by the Food and Drug Administration for use in
specific, experimental cases.
Mukpo
left Monrovia, Liberia on Sunday night and arrived in Omaha on Monday
morning. His parents saw him as he was taken off the plane and said at a
press conference Monday that they were happy his conditions had not
worsened dramatically since leaving Africa.
Duncan remains in critical condition and he is described as stable. He is on a ventilator and receiving kidney dialysis,
according to a release today from the Texas Health Presbyterian
Hospital in Dallas. Duncan's liver function, which declined over the
weekend, has improved, the hospital said.
No comments:
Post a Comment